Stifel Initiates Coverage On Evolv Technologies with Buy Rating, Announces Price Target of $12
Stifel analyst Brad Reback initiates coverage on Evolv Technologies (NASDAQ:EVLV) with a Buy rating and announces Price Target of $12.
60 Biggest Movers From Yesterday
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Evolv Technologies Q2 EPS $(0.71) Down From $(0.22) YoY, Sales $4.50M Beat $3.18M Estimate
Evolv Technologies (NASDAQ:EVLV) reported quarterly losses of $(0.71) per share. This is a 222.73 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of
Earnings Scheduled For August 16, 2021
Companies Reporting Before The Bell
• Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter.
• Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.
Understanding Evolv Technologies’s Unusual Options Activity
On Wednesday, shares of Evolv Technologies (NASDAQ:EVLV) saw unusual options activity. After the option alert, the stock price moved up to $9.72.
85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Cowen & Co. Initiates Coverage On Evolv Technologies with Outperform Rating, Announces Price Target of $14
Cowen & Co. analyst Shaul Eyal initiates coverage on Evolv Technologies (NASDAQ:EVLV) with a Outperform rating and announces Price Target of $14.
75 Biggest Movers From Friday
Gainers
The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global Management for $9 per share in all-cash transaction.